» Articles » PMID: 29540497

How Best to Capture the Respiratory Consequences of Prematurity?

Overview
Journal Eur Respir Rev
Specialty Pulmonary Medicine
Date 2018 Mar 16
PMID 29540497
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic respiratory morbidity is a common complication of premature birth, generally defined by the presence of bronchopulmonary dysplasia, both clinically and in trials of respiratory therapies. However, recent data have highlighted that bronchopulmonary dysplasia does not correlate with chronic respiratory morbidity in older children born preterm. Longitudinally evaluating pulmonary morbidity from early life through to childhood provides a more rational method of defining the continuum of chronic respiratory morbidity of prematurity, and offers new insights into the efficacy of neonatal respiratory interventions. The changing nature of preterm lung disease suggests that a multimodal approach using dynamic lung function assessment will be needed to assess the efficacy of a neonatal respiratory therapy and predict the long-term respiratory consequences of premature birth. Our aim is to review the literature regarding the long-term respiratory outcomes of neonatal respiratory strategies, the difficulties of assessing dynamic lung function in infants, and potential new solutions.

Citing Articles

Comparison of two novel diagnostic criteria for bronchopulmonary dysplasia in predicting adverse outcomes of preterm infants: a retrospective cohort study.

Wang X, Lu Y, Wu Y, Liu D, Guo J, Li M BMC Pulm Med. 2023; 23(1):308.

PMID: 37612680 PMC: 10464144. DOI: 10.1186/s12890-023-02590-6.


Prematurity-associated wheeze: current knowledge and opportunities for further investigation.

Crist A, Hibbs A Pediatr Res. 2022; 94(1):74-81.

PMID: 36463364 PMC: 10238677. DOI: 10.1038/s41390-022-02404-1.


Comparative analysis of pulmonary function in children born preterm and full-term at 6-9 years of age.

Gonzaga A, Davidson J, Goulart A, Barros M, Chiba S, Santos A Rev Paul Pediatr. 2022; 41:e2021294.

PMID: 36102403 PMC: 9462401. DOI: 10.1590/1984-0462/2023/41/2021294.


Association of early-life factors with prematurity-associated lung disease: prospective cohort study.

Hart K, Cousins M, Watkins W, Kotecha S, Henderson A, Kotecha S Eur Respir J. 2021; 59(5).

PMID: 34588197 PMC: 9095942. DOI: 10.1183/13993003.01766-2021.


Predicting Lung Health Trajectories for Survivors of Preterm Birth.

Gibbons J, Wilson A, Simpson S Front Pediatr. 2020; 8:318.

PMID: 32637389 PMC: 7316963. DOI: 10.3389/fped.2020.00318.


References
1.
Pelkonen A, Hakulinen A, Turpeinen M, Hallman M . Effect of neonatal surfactant therapy on lung function at school age in children born very preterm. Pediatr Pulmonol. 1998; 25(3):182-90. DOI: 10.1002/(sici)1099-0496(199803)25:3<182::aid-ppul8>3.0.co;2-o. View

2.
Finer N, Carlo W, Walsh M, Rich W, Gantz M, Laptook A . Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010; 362(21):1970-9. PMC: 3071534. DOI: 10.1056/NEJMoa0911783. View

3.
Halvorsen T, Skadberg B, Eide G, Roksund O, Markestad T . Better care of immature infants; has it influenced long-term pulmonary outcome?. Acta Paediatr. 2006; 95(5):547-54. DOI: 10.1080/08035250500477529. View

4.
Gerstmann D, Wood K, Miller A, Steffen M, Ogden B, Stoddard R . Childhood outcome after early high-frequency oscillatory ventilation for neonatal respiratory distress syndrome. Pediatrics. 2001; 108(3):617-23. DOI: 10.1542/peds.108.3.617. View

5.
Singh J, Sinha S, Alsop E, Gupta S, Mishra A, Donn S . Long term follow-up of very low birthweight infants from a neonatal volume versus pressure mechanical ventilation trial. Arch Dis Child Fetal Neonatal Ed. 2009; 94(5):F360-2. DOI: 10.1136/adc.2008.150938. View